Login / Signup

Identification of druggable inhibitory immune checkpoints on Natural Killer cells in COVID-19.

Olivier DemariaJulien CarvelliLuciana BatistaMarie-Laure ThibultAriane MorelPascale AndréYannis MorelFrederic VélyÉric Vivier
Published in: Cellular & molecular immunology (2020)
Keyphrases
  • natural killer cells
  • coronavirus disease
  • sars cov
  • bioinformatics analysis
  • respiratory syndrome coronavirus